[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره كنفرانس :: ثبت نام :: ارسال مقاله :: برقراري ارتباط :: راهنماي پايگاه ::
:: دوره 10، شماره 1 - ( 12-1396 ) ::
جلد 10 شماره 1 صفحات 9-15 برگشت به فهرست نسخه ها
Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia
چکیده:   (805 مشاهده)
Background: In patients undergoing chemotherapy for cancer, anemia is part of the progression of the disease. Considering the effects of anemia on quality of life of the patients, the prevention and treatment of chemotherapy-induced anemia is crucial. This study was aimed to evaluate the efficacy of recombinant human erythropoietin in reducing the need for blood transfusion in children with solid tumors receiving chemotherapy.
Methods: In a clinical trial, 57 children referred to the pediatric centre of Tabriz University of Medical Sciences with a diagnosis of solid tumor were randomly assigned into two groups. The intervention group (n=29) received recombinant human erythropoietin (rHuEPO) at a dose of 450 IU/kg subcutaneously once a week for 12 weeks, and the control group (n=28) received no intervention in this regard. Hemoglobin levels were analysed at the beginning and end of the study. The need for blood transfusion was also assessed in the patients.
Results: The mean Hb at the beginning of the study was 8.85±1.01 and 8.98±0.11 g in the intervention and control groups, respectively. The mean Hb at the end of the study was 9.78±0.32 g/dl in the intervention group and 7.79±0.24 g/dl in the control group. Hb level was significantly higher in the intervention group at the end of the 12 weeks of treatment with rHuEPO than in the control group (P=0.001).
Conclusion: Based on the results of this study, rHuEPO administration seems to be beneficial in the prevention and treatment of chemotherapy-induced anemia in children with solid tumors and reduces the amount of blood transfusion in these patients.
متن کامل [DOCX 113 kb]   (506 دریافت)    
: پژوهشي | موضوع مقاله: Pediatric Hematology & Oncology
دریافت: ۱۳۹۶/۱۰/۱۶ | پذیرش: ۱۳۹۶/۱۲/۹ | انتشار: ۱۳۹۷/۲/۱۷
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA code


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hiradfar A A, Rezamand A, Pourghasem M, Karkon Shayan S, Ghamari B, Karkon Shayan F. Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia. IJBC. 2018; 10 (1) :9-15
URL: http://ijbc.ir/article-1-779-fa.html

Recombinant Human Erythropoietin in Children with Solid Tumors and Chemotherapy-induced Anemia. مجله خون و سرطان ايران. 1396; 10 (1) :9-15

URL: http://ijbc.ir/article-1-779-fa.html



دوره 10، شماره 1 - ( 12-1396 ) برگشت به فهرست نسخه ها
مجله ی خون و سرطان ایران Iranian Journal of Blood and Cancer
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3781